Sarcoidosis in the United Kingdom: Findings from the first decade of the UK ILD Registry - Vienna 2024

Sarcoidosis: novel insights in disease epidemiology, immunology and treatment

Chair(s): Marcel Veltkamp, Natalia V. Rivera

Session type: Oral presentation

Sarcoidosis in the United Kingdom: Findings from the first decade of the UK ILD Registry

Andrew Achaiah

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Deciphering disagreement: sarcoidosis management and the role of FDG-PET/CT

Ryan Donnelly

Replay

Poster

Abstract

Slides

Effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis

Vivienne Kahlmann

Replay

Poster

Abstract

Slides

BERYSARC: a multicentric control case study comparing chronic beryllium disease to pulmonary sarcoidosis

C?cile Rotenberg

Replay

Poster

Abstract

Slides

Usual interstitial pneumonia (UIP) pattern in pulmonary sarcoidosis

Gioele Castelli

Replay

Poster

Abstract

Slides

Late Breaking Abstract - Evaluation of the antifibrotic activity of bexotegrast, a dual ?V?6/?V?1 integrin inhibitor, in precision-cut lung slices prepared from non-IPF interstitial lung disease explants

Johanna Schaub

Replay

Poster

Abstract

Slides

Deciphering the genetic tapestry: Insights into sarcoidosis across diverse populations with the MESARGEN Consortium

Natalia V. Rivera

Replay

Poster

Abstract

Slides

Dissecting the immune cell niche in pulmonary sarcoidosis CXCL10+ monocyte-derived macrophages are potential drivers of TH17.1 inflammation

Jannik Ruwisch

Replay

Poster

Abstract

Slides

Sarcoidosis in the United Kingdom: Findings from the first decade of the UK ILD Registry

Andrew Achaiah

Replay

Poster

Abstract

Slides

RESOLVE-LUNG, a multinational, randomized, placebo-controlled Phase II trial of namilumab, an anti-GMCSF monoclonal antibody, in chronic pulmonary sarcoidosis: trial design and patient characteristics

Bernt Van Den Blink

Replay

Poster

Abstract

Slides

A population-based matched cohort study of sarcoidosis incidence, prevalence, and all-cause mortality. The HUNT study

Astrid Gjervold Lunde

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}